ASTRAZENECA PLC CEDEAR EACH REP 0.5 ADR USD0.25ASTRAZENECA PLC CEDEAR EACH REP 0.5 ADR USD0.25ASTRAZENECA PLC CEDEAR EACH REP 0.5 ADR USD0.25

ASTRAZENECA PLC CEDEAR EACH REP 0.5 ADR USD0.25

No trades
See on Supercharts

ASTRAZENECA PLC CEDEAR EACH REP 0.5 ADR USD0.25 discussion

AZN flying to level of butterfly target
Snapshot

AZN Crossed over 200EMA, and coming out from a daily negative trend channel.Interesting indeed.

AZN developing capivasertib (triple negative breast cancer) and AZD3252 (Covid) both phase 3 trials expected to be complete by end of June 2024.

AZN long position 1D
Snapshot

AZN long position 15m
Snapshot

Nice setup ??
Snapshot